Literature DB >> 9542914

Identification and purification of specific Penicillium marneffei antigens and their recognition by human immune sera.

L Jeavons1, A J Hamilton, N Vanittanakom, R Ungpakorn, E G Evans, T Sirisanthana, R J Hay.   

Abstract

Disseminated infection with the dimorphic pathogenic fungus Penicillium marneffei is increasingly seen among patients with AIDS in southeast Asian countries. Previous studies have demonstrated the presence of humoral immune responses to this fungus in patient sera; we have confirmed this work using sera from P. marneffei-infected patients (n = 21) to develop Western blots of P. marneffei cytoplasmic yeast antigen (CYA). P. marneffei CYA was then partially purified by liquid isoelectric focusing, and fractions were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. Immunoenzyme development of the Western blots with pooled sera from patients with P. marneffei infection and with pooled sera from patients with aspergillosis (n = 20), candidiasis (n = 10), cryptococcosis (n = 9), and histoplasmosis (n = 11) revealed three antigens with relative molecular masses of 61, 54, and 50 kDa. These antigens were specifically recognized by the pooled sera from the P. marneffei-infected patients. The 61- and 54-kDa antigens were subsequently purified to homogeneity by preparative gel electrophoresis, and the 50-kDa antigen was partially purified by the same technique. N-terminal amino acid sequencing revealed that the 61-kDa antigen had a strong homology (87% identity) with the antioxidant enzyme catalase. The three antigens were then subjected to SDS-PAGE and Western blotting and to immunoenzyme development with individual patient sera; sera from 86% of P. marneffei-infected patients recognized the 61-kDa antigen, sera from 71% recognized the 54-kDa antigen, and sera from 48% recognized the 50-kDa antigen. These specifically recognized antigens are the first to be purified from P. marneffei and can be used either singly or in combination to detect antibody responses in a large percentage of individuals infected with P. marneffei.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9542914      PMCID: PMC104666          DOI: 10.1128/JCM.36.4.949-954.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  An immunodominant 90-kilodalton Aspergillus fumigatus antigen is the subunit of a catalase.

Authors:  R López-Medrano; M C Ovejero; J A Calera; P Puente; F Leal
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

2.  Immunological characterization of a recombinant 27-kilodalton antigenic protein from Paracoccidioides brasiliensis.

Authors:  B L Ortiz; A M Garcia; A Restrepo; J G McEwen
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

3.  Western immunoblot analysis of protein antigens of Penicillium marneffei.

Authors:  N Vanittanakom; M Mekaprateep; N Sittisombut; K Supparatpinyo; P Kanjanasthiti; K E Nelson; T Sirisanthana
Journal:  J Med Vet Mycol       Date:  1997 Mar-Apr

4.  Serodiagnosis of Penicillium marneffei infection.

Authors:  K Y Yuen; S S Wong; D N Tsang; P Y Chau
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

5.  Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein.

Authors:  S M Read; D H Northcote
Journal:  Anal Biochem       Date:  1981-09-01       Impact factor: 3.365

6.  Evidence that the M antigen of Histoplasma capsulatum var. capsulatum is a catalase which exhibits cross-reactivity with other dimorphic fungi.

Authors:  A J Hamilton; M A Bartholomew; J Figueroa; L E Fenelon; R J Hay
Journal:  J Med Vet Mycol       Date:  1990

Review 7.  Penicillium marneffei infection: an underdiagnosed disease?

Authors:  D N Tsang; J K Chan; Y T Lau; W Lim; C H Tse; N K Chan
Journal:  Histopathology       Date:  1988-09       Impact factor: 5.087

Review 8.  Disseminated Penicillium marneffei infection associated with human immunodeficiency virus: a report of two cases and a review of 35 published cases.

Authors:  I Hilmarsdottir; J L Meynard; O Rogeaux; G Guermonprez; A Datry; C Katlama; G Brücker; A Coutellier; M Danis; M Gentilini
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-05

9.  Immunochemical studies of heat-shock protein 80 of Histoplasma capsulatum.

Authors:  L Jeavons; L Hunt; A Hamilton
Journal:  J Med Vet Mycol       Date:  1994

10.  Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei.

Authors:  L Kaufman; P G Standard; S A Anderson; M Jalbert; B L Swisher
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

View more
  12 in total

Review 1.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Rapid identification of Penicillium marneffei by PCR-based detection of specific sequences on the rRNA gene.

Authors:  Nongnuch Vanittanakom; Pramote Vanittanakom; Roderick J Hay
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

3.  Biotyping of Penicillium marneffei reveals concentration-dependent growth inhibition by galactose.

Authors:  S S Wong; T Y Ho; A H Ngan; P C Woo; T L Que; K Y Yuen
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei.

Authors:  Varunee Desakorn; Andrew J H Simpson; Vanaporn Wuthiekanun; Duangjai Sahassananda; Adul Rajanuwong; Punnee Pitisuttithum; Paul A Howe; Michael D Smith; Nicholas J White
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  A novel inhibition ELISA for the detection and monitoring of Penicillium marneffei antigen in human serum.

Authors:  K Prakit; J D Nosanchuk; K Pruksaphon; N Vanittanakom; S Youngchim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-02       Impact factor: 3.267

6.  Acute Penicillium marneffei infection stimulates host M1/M2a macrophages polarization in BALB/C mice.

Authors:  Xiaoying Dai; Congzheng Mao; Xiuwan Lan; Huan Chen; Meihua Li; Jing Bai; Jingmin Deng; Qiuli Liang; Jianquan Zhang; Xiaoning Zhong; Yi Liang; Jiangtao Fan; Honglin Luo; Zhiyi He
Journal:  BMC Microbiol       Date:  2017-08-18       Impact factor: 3.605

7.  An inexpensive point-of-care immunochromatographic test for Talaromyces marneffei infection based on the yeast phase specific monoclonal antibody 4D1 and Galanthus nivalis agglutinin.

Authors:  Kritsada Pruksaphon; Akarin Intaramat; Pavinee Simsiriwong; Skorn Mongkolsuk; Kavi Ratanabanangkoon; Joshua D Nosanchuk; Anna Kaltsas; Sirida Youngchim
Journal:  PLoS Negl Trop Dis       Date:  2021-05-04

8.  Characterization of a novel yeast phase-specific antigen expressed during in vitro thermal phase transition of Talaromyces marneffei.

Authors:  Kritsada Pruksaphon; Mc Millan Nicol Ching; Joshua D Nosanchuk; Anna Kaltsas; Kavi Ratanabanangkoon; Sittiruk Roytrakul; Luis R Martinez; Sirida Youngchim
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

9.  Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen by using an enzyme immunoassay.

Authors:  V Desakorn; M D Smith; A L Walsh; A J Simpson; D Sahassananda; A Rajanuwong; V Wuthiekanun; P Howe; B J Angus; P Suntharasamai; N J White
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei.

Authors:  Kritsada Pruksaphon; Akarin Intaramat; Kavi Ratanabanangkoon; Joshua D Nosanchuk; Nongnuch Vanittanakom; Sirida Youngchim
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.